Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.
Joined June 2018
- Tweets 1,971
- Following 1,166
- Followers 1,101
- Likes 5,966
262 Photos and videos
Evan Hall retweeted
13 Nov 2024
Fantastic @StanfordDeptMed Grand Rounds now for the memorial @BGabster lecture
@DianaCejasMD presents on writing and illness. & some basic neuroanatomy for us internists
A special gathering for our community. Our gratitude to Dr. Gabster’s family.
medicine.stanford.edu/news/c…
1
7
23
2,060
Evan Hall retweeted
14 Nov 2024
The Phase 2/3 Randomized trial of RP2 nivolumab for #uveal #melanoma is now OPEN at @StanfordCancer. This is for patients who have not had prior checkpoint inhibitors or liver-directed therapy. Prior tebentafusp is allowed. The phase 1 data were quite promising and we're excited to be able to offer this to our patients!
3
10
32
7,468
Evan Hall retweeted
9 Nov 2024
Representing @fredhutch @UWMedicine @uwsomwwami Kidney Cancer Multidisciplinary Team #IKCSNA2024 @KidneyCancer @spsutkaMD
2
13
1,278
Evan Hall retweeted
8 Nov 2024
Nice to see this out there! Dr. Silk did a heroic job leading this trial of tvec and nivolumab in rare skin cancers. A collaboration that has spanned many institutions! @Perlmutter_CC @DanaFarber @theNCI @RutgersCancer
2
8
31
2,860
Evan Hall retweeted
7 Nov 2024
Fantastic work @LisaTachiki @BhatiaS_MD @fredhutch et al.
@FredHutchGO @HutchPresident @nicoleflemingmd @JessicaHawleyMD @RahulBanerjeeMD @EvanHallMD @btfoundation @binayshah @MonikaJoshimd @UWMedicine @AJPortuguese @HannahRAbrams @natashakwemd @valdesan @OncoAlert @sitcancer
1
7
19
4,376
Evan Hall retweeted
15 Oct 2024
New #JITC article: Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses bit.ly/4dIbUHP @BhatiaS_MD @PaulNghiem
3
11
1,042
11 Oct 2024
@DrBetofMDPhD @StanfordCancer presents on TIL for patients with untreated brain metastases post PD-1 at #SMR24. Very important area to generate data. Time for TIL process, need for anesthesia/harvest, chemotherapy causing ⬇️plts, IL-2 etc complicate this scenario. 1/
3
2
13
993
11 Oct 2024
Very thoughtfully designed study. Good rationale to reduce intensity of lymphodepletion. TIL can produce intracranial responses in some patients! Clearly, some pts have explosive disease kinetics and cannot wait (even w bridging) for this approach, but good to have pilot data 2/
1
4
558
Evan Hall retweeted
10 Oct 2024
Very proud to be part of multidisciplinary kidney cancer clinic @fredhutch providing 1 stop service for kidney cancer patients@spsutkaMD @DanLinMD @schadegr @EvanHallMD @LisaTachiki @WinstonVuong @MartinMaMDPhD
4
2
21
1,431
Evan Hall retweeted
7 Sep 2024
Find yourself doctors (and colleagues) that get excited about moving the field forward like @alexshoushtari and @DrBetofMDPhD
Reunion of kindred spirits this morning at Living with Melanoma @AIMatMelanoma and @StanfordCancer
1
2
22
877
Evan Hall retweeted
19 Aug 2024
Are you interested in how to select side-effects for ePRO symptom monitoring ?
We conducted a national modified Delphi to do just that for #immunotherapy side-effects in routine care and found limited coverage of clinically relevant side-effects by existing PROMs @JCOOP_ASCO
2
13
40
3,218
Evan Hall retweeted
3 Aug 2024
Excited to present @ASCO highlights in GU cancers in @ScrippsHealth in Seattle! So much great data to cover! @fredhutch @shilpaonc @Uromigos @urotoday @OncoAlert @valdesan @EvanHallMD @BhatiaS_MD @JessicaHawleyMD @RahulBanerjeeMD @montypal @neerajaiims @jrgralow @TiansterZhang
1
5
43
2,441
Evan Hall retweeted
21 Jul 2024
That Seattle 5k was fantastic! 🤩
We had 122 people race for a cure with us! Thank you to each and every one of you! We are so appreciative of all of your support! 🥇
We were able to raise over $10,000! 👏 👏 👏
And we'd like to thank @fredhutch for sponsoring this event!
1
2
205
Evan Hall retweeted
14 Jul 2024
Heard this today at a funeral and it hit me like a ton of bricks
8
15
250
14,883
Evan Hall retweeted
17 Jun 2024
I don’t know who else needs to hear this, but I know I did
17
101
717
86,513
Evan Hall retweeted
14 Jun 2024
Check out our latest paper on the development of the new @EORTC_QLG advanced #melanoma module.
Great to contribute 🇦🇺 perspectives from @MelanomaAus. @PeterMacCC patients will also be included in Phase 3. #melsm
authors.elsevier.com/c/1jFvH…
1
9
26
1,768
Evan Hall retweeted
4 Jun 2024
As the sun sets on #asco24 I’d be remiss not to say that I’m worried about my colleagues
I worry we are crushing one another with colossal expectations, with our emails & CVs
You are more than your publications & presentations
Please don’t tie your self-worth to brass rings
13
84
658
100,850
Evan Hall retweeted
4 Jun 2024
#irAE outcomes needs to be right next to Progression free survival and Disease free survival as a core outcome.
Thank you @jillfeldman4 @thenasheffect @EladSharonMD @FunchainMD for amplifying this message.
#ASCO24
3 Jun 2024
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
#ASCO24
4
10
1,315
Evan Hall retweeted
4 Jun 2024
Right on @jillfeldman4 ! Understanding and mitigating irAEs especially the long term ones that affect quality of life for many people post IO needs to be a high priority area!
@DrJNaidoo @EladSharonMD @FunchainMD @kreynoldsMD @ACortelliniMD @BiagioRicciutMD @afreenshariffmd
3 Jun 2024
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
TOXICITY is the top reason for checkpoint inhibitor discontinuation
#ASCO24
1
5
27
3,920
Evan Hall retweeted
4 Jun 2024
#irAE Outcomes should be reported right next to progression free survival and disease-free survival outcomes.
Thank you @jillfeldman4 @thenasheffect @EladSharonMD @FunchainMD @EvanHallMD @ASCOPost for amplifying this message.
#ASCO24
4 Jun 2024
Right on @jillfeldman4 ! Understanding and mitigating irAEs especially the long term ones that affect quality of life for many people post IO needs to be a high priority area!
@DrJNaidoo @EladSharonMD @FunchainMD @kreynoldsMD @ACortelliniMD @BiagioRicciutMD @afreenshariffmd
1
2
6
1,088